Mills Kenneth T.

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Jul 26, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$383K
Net Open-Market Flow
-$383K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2024Option exercise(M)15K$3.76$58K423K
Jul 25, 2024Sell(S)15K$13.96$215K408K
Jul 24, 2024Sell(S)12K$13.78$168K408K
Jul 24, 2024Option exercise(M)12K$3.76$46K420K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 25, 2024Option exercise(M)15K$051K
Jul 24, 2024Option exercise(M)12K$067K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-005855) within minutes of acceptance. Every field above traces to the original document. Verify it directly: